Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study

Abstract Background Although studies have revealed the benefits of using dexmedetomidine (DEX) in treating rodent models of acute lung injury (ALI) by improving their survival rates, clinical investigation on the effect of DEX on patients with acute respiratory distress syndrome (ARDS) remains scarc...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianguo Zhang, Zhaoyuan Jia, Yu Zhang, Zhimin Tao
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-025-02961-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849774507082907648
author Jianguo Zhang
Zhaoyuan Jia
Yu Zhang
Zhimin Tao
author_facet Jianguo Zhang
Zhaoyuan Jia
Yu Zhang
Zhimin Tao
author_sort Jianguo Zhang
collection DOAJ
description Abstract Background Although studies have revealed the benefits of using dexmedetomidine (DEX) in treating rodent models of acute lung injury (ALI) by improving their survival rates, clinical investigation on the effect of DEX on patients with acute respiratory distress syndrome (ARDS) remains scarce. Through this retrospective study, we aim to better understand the underlying mechanism of sepsis-induced ARDS and the effect of DEX on patients’ standard treatment. Methods A total of 208 patients with sepsis-induced ARDS, admitted to the intensive care unit (ICU) at Affiliated Hospital of Jiangsu University, China, from January 2017 to December 2019, were included. The patients were divided into the control group (n = 102) and the DEX group (n = 106). Both groups of patients received mechanical ventilation and standard care; however, the DEX group was additionally treated with DEX as a sedative. Demographic information, baseline characteristics, laboratory parameters, arterial blood gas (ABG) analyses, and inflammatory indicators were compared between the two groups to evaluate the therapeutic outcomes of different treatment approaches. Results Age and male gender constituted risk factors for high ARDS incidence, and hypertension led in the list of patients’ comorbidities. The baseline characteristics including primary diagnosis and ARDS causes, and prognostic values such as the Acute Physiology and Chronic Health Evaluation (APACHE) II score and predicted mortality, were comparable between the two groups of patients. However, the multiple organ dysfunction syndrome (MODS) incidence and actual mortality rate were significantly lower in the DEX group compared to the control group. Additionally, the DEX group demonstrated improved ABG metrics, representing better acid-base balance and oxygenation, and enhanced inflammatory responses. Conclusions Intravenous administration of DEX was associated with reduced in-hospital mortality, at least in part, by ameliorating ABG indices and inflammatory mediators.
format Article
id doaj-art-1e53265dff7445febeee30697ab3db31
institution DOAJ
issn 1471-2253
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj-art-1e53265dff7445febeee30697ab3db312025-08-20T03:01:41ZengBMCBMC Anesthesiology1471-22532025-03-0125111110.1186/s12871-025-02961-yDexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective studyJianguo Zhang0Zhaoyuan Jia1Yu Zhang2Zhimin Tao3Department of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityDepartment of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityDepartment of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityDepartment of Emergency Medicine, Affiliated Hospital of Jiangsu UniversityAbstract Background Although studies have revealed the benefits of using dexmedetomidine (DEX) in treating rodent models of acute lung injury (ALI) by improving their survival rates, clinical investigation on the effect of DEX on patients with acute respiratory distress syndrome (ARDS) remains scarce. Through this retrospective study, we aim to better understand the underlying mechanism of sepsis-induced ARDS and the effect of DEX on patients’ standard treatment. Methods A total of 208 patients with sepsis-induced ARDS, admitted to the intensive care unit (ICU) at Affiliated Hospital of Jiangsu University, China, from January 2017 to December 2019, were included. The patients were divided into the control group (n = 102) and the DEX group (n = 106). Both groups of patients received mechanical ventilation and standard care; however, the DEX group was additionally treated with DEX as a sedative. Demographic information, baseline characteristics, laboratory parameters, arterial blood gas (ABG) analyses, and inflammatory indicators were compared between the two groups to evaluate the therapeutic outcomes of different treatment approaches. Results Age and male gender constituted risk factors for high ARDS incidence, and hypertension led in the list of patients’ comorbidities. The baseline characteristics including primary diagnosis and ARDS causes, and prognostic values such as the Acute Physiology and Chronic Health Evaluation (APACHE) II score and predicted mortality, were comparable between the two groups of patients. However, the multiple organ dysfunction syndrome (MODS) incidence and actual mortality rate were significantly lower in the DEX group compared to the control group. Additionally, the DEX group demonstrated improved ABG metrics, representing better acid-base balance and oxygenation, and enhanced inflammatory responses. Conclusions Intravenous administration of DEX was associated with reduced in-hospital mortality, at least in part, by ameliorating ABG indices and inflammatory mediators.https://doi.org/10.1186/s12871-025-02961-ySepsisAcute respiratory distress syndromeDexmedetomidineBlood oxygenationInflammatory response
spellingShingle Jianguo Zhang
Zhaoyuan Jia
Yu Zhang
Zhimin Tao
Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
BMC Anesthesiology
Sepsis
Acute respiratory distress syndrome
Dexmedetomidine
Blood oxygenation
Inflammatory response
title Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
title_full Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
title_fullStr Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
title_full_unstemmed Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
title_short Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
title_sort dexmedetomidine administration is associated with reduced mortality in patients with sepsis induced acute respiratory distress syndrome a retrospective study
topic Sepsis
Acute respiratory distress syndrome
Dexmedetomidine
Blood oxygenation
Inflammatory response
url https://doi.org/10.1186/s12871-025-02961-y
work_keys_str_mv AT jianguozhang dexmedetomidineadministrationisassociatedwithreducedmortalityinpatientswithsepsisinducedacuterespiratorydistresssyndromearetrospectivestudy
AT zhaoyuanjia dexmedetomidineadministrationisassociatedwithreducedmortalityinpatientswithsepsisinducedacuterespiratorydistresssyndromearetrospectivestudy
AT yuzhang dexmedetomidineadministrationisassociatedwithreducedmortalityinpatientswithsepsisinducedacuterespiratorydistresssyndromearetrospectivestudy
AT zhimintao dexmedetomidineadministrationisassociatedwithreducedmortalityinpatientswithsepsisinducedacuterespiratorydistresssyndromearetrospectivestudy